Harrow Health reported total revenues of $13.5 million in the second quarter of 2019 compared with $10.4 million in the same period a year ago, according to a press release.
Net loss was $2.4 million, or $0.09 per basic share, compared with a net income of $2.5 million, or $0.12 per basic share, in the second quarter of 2018.
Selling, general and administrative expenses totaled $8.2 million in the second quarter of 2019 vs. $6.8 million in the second quarter of 2018. Research and development expenses were $810,000 compared with (Read more...)
Uncategorized